These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15746859)

  • 1. Surgical management of Meniere's disease in the era of gentamicin.
    Kaylie DM; Jackson CG; Gardner EK
    Otolaryngol Head Neck Surg; 2005 Mar; 132(3):443-50. PubMed ID: 15746859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP; Din S; Atlas MD
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
    Kasemsuwan L; Jariengprasert C; Chaturapatranont S
    J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT; Minor LB; Della Santina CC; Carey JP
    Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endolymphatic sac shunt, labyrinthectomy, and vestibular nerve section in Meniere's disease.
    Teufert KB; Doherty J
    Otolaryngol Clin North Am; 2010 Oct; 43(5):1091-111. PubMed ID: 20713247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of endolymphatic mastoid shunt surgery in patients with intractable Ménière's disease.
    Yu MS; Lee KS; Chung JW
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):237-42. PubMed ID: 19643258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M; Marsan J; Schramm D; Robichaud J
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Ménière's disease.
    Brinson GM; Chen DA; Arriaga MA
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):415-21. PubMed ID: 17321870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary role of endolymphatic mastoid shunt surgery in the era of transtympanic perfusion strategies.
    Lee L; Pensak ML
    Ann Otol Rhinol Laryngol; 2008 Dec; 117(12):871-5. PubMed ID: 19140530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple semicircular canal occlusion for the treatment of Ménière's disease.
    Yin S; Chen Z; Yu D; Wu Y; Shi H; Zhou H; Wang J
    Acta Otolaryngol; 2008 Jul; 128(7):739-43. PubMed ID: 18568514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the diagnosis and the management of Meniere's disease: results of a survey.
    Kim HH; Wiet RJ; Battista RA
    Otolaryngol Head Neck Surg; 2005 May; 132(5):722-6. PubMed ID: 15886625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of second-echelon treatments for Ménière's disease.
    Basura GJ; Lin GC; Telian SA
    JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):754-61. PubMed ID: 25057891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Individual management of Meniere's disease and evaluation of functional outcome].
    Chen Y; Yang J; Wu H; Huang Q; Wang Z; Zhang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 25(16):721-5. PubMed ID: 22070076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.